ClinicalTrials.gg
RecruitingNCT07254299HypnoPICSUpdated Nov 10, 2026

Hypnosis to Improve Well-beings of Critically Ill Patients and Prevent Post-intensive Care Syndrome

An interventional study of Hypnosis in Post Intensive Care Syndrome (PICS), sponsored by COEN Matteo. Recruiting at 2 sites in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by COEN Matteo · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Mar 2026; still recruiting 8 months later.
Updated Nov 10, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to evaluate the effectiveness of a hypnosis intervention in improving well-being at day 28 of an ICU stay. The main question it aims to answer is :

-Does Hypnosis intervention at ICU discharge and on day 7 and 14 on the wards if the patient remains in the hospital, improve wellbeing at 28 days ?

Researchers will compare discharged ICU patients who received standard post-discharge care to discharged ICU patients who received standard post-discharge care and hypnosis intervention on discharge and 7 and 14days after if they are still in the hospital, to see if hypnosis can improve their wellbeing.

Participants will receive a hypnosis session on the day of ICU discharge, a second session seven days post-discharge and a third session at day 14 if they are still in the hospital.

Read the detailed description

Critically ill patients in the Intensive Care Unit (ICU) face numerous challenges both acutely and in the long term. These patients frequently experience acute pain and anxiety due to intubation and induced comas. Following their ICU discharge, they commonly report decreased well-being and quality of life. Additionally, up to 40% of critically ill patients develop post-intensive care syndrome (PICS), which includes mental, physical, and cognitive sequelae that can persist up to one year after discharge. Heavy sedation and medications necessary to manage pain and anxiety are known risk factors for PICS.

The current standard of care in the ICU includes mobilization and nutrition, pain control, and family engagement and empowerment. Furthermore, no other specific interventions are aimed at improving long-term outcomes and preventing PICS.

Several studies have explored using hypnosis to improve the acute care of ICU patients. For instance, a pain protocol that included hypnosis in burn patients hospitalized in the CHUV (Centre Hospitalier Universitaire Vaudois) resulted in reduced pain intensity, reduced opioid use, reduced anxiety, and better wound outcomes, all while lowering costs. A pilot study involving non-invasive ventilation patients showed that hypnosis could improve comfort, mask tolerance, and anxiety levels. Additionally, studies on relaxation therapy have indicated that electronic relaxation therapy is a promising, safe, and effective non-pharmacological solution to enhance overall comfort in alert and non-delirious ICU patients.

However, despite these efforts, there is a lack of efficient interventions specifically targeting the wellbeing of patients after an ICU stay and the prevention of PICS. Existing interventions, such as follow-up programs, rehabilitation, and psychological follow-up, have shown conflicting results. To date, no studies have specifically assessed the effect of hypnosis on the short and longer-term well-being of critically ill patients leaving the ICU and its possible effect on the prevention of PICS.

The investigators hypothesize that providing a hypnosis session at ICU discharge and followed by subsequent sessions on days 7 and 14 on the ward will improve well-being in the short term and reduce PICS symptoms at 3-months. The primary outcome will be the assessment of well-being at day 28 post-ICU discharge. Secondary outcomes will be anxiety, depression, PTSD, and quality of life at three months.

Hypothesis and primary objective The investigators hypothesize that providing intervention with hypnosis at ICU discharge and subsequent sessions on day 7 and 14 on the ward if the patient remains in the hospital will improve wellbeing at day 28 and reduce PICS symptoms at three months in critically ill patients.

Primary Objective:

The primary objective of this study is to evaluate the effectiveness of a hypnosis intervention in improving well-being at day 28 of an ICU stay.

Scale used for wellbeing:

  • ESAS, total 90, each item on a 0-10 scale
  • EQ-5D-5L

Secondary Objectives:

  1. To assess the impact of a hypnosis intervention to improve PICS at 3 months

    • Anxiety and depression: PHQ-9 et GAD-7
    • Post-traumatic stress disorder: PDI and IES-R scale
    • Quality of life: SF-12, EQ-5D-5L and WHODAS 2.0
    • Patient impression of change: PGIC
  2. To evaluate patient immediate wellbeing after the hypnosis intervention. • ESAS before after the session in patients who will get the session
02

Conditions studied

  • Post Intensive Care Syndrome (PICS)

Keywords

  • post intensive care syndrome
  • randomized controlled trail
  • hypnosis
03

In context

postintensive care syndrome

106 studies on the registry are indexed under postintensive care syndrome; 49 are open to participants now.

This study's planned enrollment of 150 is above the median of 79 across 48 interventional studies indexed under postintensive care syndrome.

Browse postintensive care syndrome studies →

Lead sponsor

This is the only study on the registry with COEN Matteo as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • On Mechanical Ventilation for at least 2 days
  • Able to give as documented by signature
  • French speaking

Exclusion criteria

Exclusion Criteria:

  • Refusal of the patient
  • Patient transferred from another ICU
  • Patient is planned for a withdrawal of care or is actively dying
  • Glasgow coma scale (GCS) \<15 on ICU discharge
  • Patient presenting with delirium (detected by CAM-ICU) on ICU discharge
  • Patient hospitalized for traumatic brain injury
  • Patient is in jail
  • Patient hospitalized for more than 28 days in the ICU
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
150 participants (estimated)

Study arms

  • Experimental
    Hypnosis group

    Participants in the intervention group will receive a hypnosis session on the day of discharge, a second session seven days post-discharge, and a third session on day 14 if they are still in the hospital. Trained professionals will conduct the hypnosis sessions following a standardized protocol, designed by the study team for critically ill patients.

    Other: Hypnosis

  • No intervention
    Control group

    Participants in the control group will receive standard post-discharge care, which includes mobilization, nutrition, pain control, and family engagement and empowerment, without any hypnosis intervention.

Interventions

  • OtherHypnosis

    the hypnosis will be tailored to each patient. Key elements will include relaxation (to mitigate anxiety and stress and help the patient feel more comfortable, secure, and competent), reassociation techniques (to help the patient reconnect with their body, promoting a sense of embodiment and presence), and safe place (to introduce a safe and calming place to instill a sense of control and competence, aiding in emotional stabilization and fostering a sense of safety and well-being).

06

What researchers measure

Primary outcomes

  1. Wellbeing at day 28 post intensive care unit discharge

    ESAS scale (Edmonton Symptom Assessment System) with a range from 0 to 100. Higher scores means worse wellbeing.

    Time frame: Day 28 post intensive care unit discharge

Secondary outcomes

  1. Immediate wellbeing following a hypnosis session

    1\) ESAS scale before and after the hypnosis session performed on Day 1 (ICU discharge), Day 7 and D14 -The ESAS scale (Edmonton Symptom Assessment System) has a range from 0 to 100.

    Time frame: Day 1 (Day of discharge from ICU), day 7, day 14

  2. PDI - Peritraumatic distress inventory

    PDI (Peritraumatic distress index, range: 13-65)

    Time frame: day 28 post ICU discharge

  3. PHQ-9 - Patient Health Questionnaire-9

    PHQ-9 (Patient Health Questionnaire-9: range 0-27) will be used to assess depressive symptoms at day 28 and 3 months

    Time frame: Day 28 post intensive care unit discharge and 3 months post intensive care

  4. GAD-7 - Generalized Anxiety Disorder-7

    GAD-7 (Generalized Anxiety Disorder-7, range 0-21) will be used to assess anxiety symptoms at day 28 and 3 months post ICU discharge

    Time frame: at day 28 and 3 months post ICU discharge

  5. IES-R (Impact of event Scale)

    Range: 0-88

    Time frame: 3 months post intensive care unit discharge. Higher score means more PTSD symptoms.

  6. EQ-5D-5L (Quality of life)

    Part 1) 5 dimensions: Mobility, Self-care, Usual activities, Pain/discomfort, Anxiety/depression. The 5-digit health state is converted (via country-specific value set) to an index value Part 2) EQ VAS (Visual Analog Scale). Patient rates their health today from 0 to 100. Higher scores mean better quality of life.

    Time frame: Day 28 post intensive care unit discharge and 3 months post intensive care unit discharge

  7. PGIC - Patient Global Impression of Change

    Single-item global rating of how much the patient feels their condition has changed since a reference time. Higher scores means improvement. Scoring / range: 1-7

    Time frame: Day 28 post intensive care unit discharge and 3 months post intensive care unit discharge

07

Study locations

1 of 2 sites recruiting
  • University Hospital of Geneva
    Geneva, 1205, Switzerland
    Recruiting
  • Hôpitaux Neuchâtelois
    Neuchâtel, Switzerland
    Not yet recruiting
    • Marie-Eve Brunner, Medical Doctor · Contact
08

References and documents

Publications

  • Schmidt B, Schneider J, Deffner T, Rosendahl J. Hypnotic suggestions of safety improve well-being in non-invasively ventilated patients in the intensive care unit. Intensive Care Med. 2021 Apr;47(4):485-486. doi: 10.1007/s00134-021-06364-8. Epub 2021 Feb 16. No abstract available. PubMed 33590259 ↗
  • Spiegel D, Cardena E. New uses of hypnosis in the treatment of posttraumatic stress disorder. J Clin Psychiatry. 1990 Oct;51 Suppl:39-43; discussion 44-6. PubMed 2211565 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Oct 2027, 18 months after the start.

Of 40 interventional studies with no phase under postintensive care syndrome, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 38. This study's planned 18 months is below that.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 10, 2026: primary completion Mar 2027 → Oct 2027 and completion Mar 2027 → Dec 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Nov 14, 2025
First posted
Nov 28, 2025
StartActual
Mar 16, 2026
Primary completionEst.
Oct 1, 2027was Mar 2027
CompletionEst.
Dec 1, 2027was Mar 2027
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Mar 1, 2027→Oct 1, 2027
Nov 10, 2026
Study completion
Mar 1, 2027→Dec 1, 2027
Nov 10, 2026
Show all 1 update
  1. Nov 10, 2026
    Primary completion Mar 1, 2027→Oct 1, 2027
    Study completion Mar 1, 2027→Dec 1, 2027
    + 2 other changes: identifiers and verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07254299
Lead sponsor
COEN Matteo
Responsible party
COEN Matteo (Dr. med. PD. PhD, University Hospital, Geneva) — Sponsor-investigator
First posted
Nov 28, 2025
Start date
Mar 16, 2026
Primary completion
Oct 1, 2027 (estimated)
Completion
Dec 1, 2027 (estimated)
Last update
Nov 10, 2026

Study contacts

Hannah Wozniak, Medical Doctor
Contact
hannah-wozniak@hug.ch
+41
Jennifer B. C. S Muradbegovic, Doctor
Contact
jennifer.cau@hug.ch
+41 79 55 36255
Hannah Wozniak, Medical Doctor
principal investigator · University Hospital, Geneva
Matteo Coen, MD, PHD
principal investigator · University Hospital, Geneva

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion